ResearcherMcGill University Health CentreActive in the last 2 years
Pnina Brodt
Matched on ORCID iD 0000-0002-8977-7179; OpenAlex author ID A5049237612. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1158/0008-5472.can-24-0744↗
- The oncofetal protein IMP1 regulates the transcriptomic landscape to drive early events in pancreatic cancer progression and growth Last author DOI 10.1101/2024.06.28.601273↗
- Targeting the IGF-Axis Potentiates Immunotherapy for Pancreatic Ductal Adenocarcinoma Liver Metastases by Altering the Immunosuppressive Microenvironment. Last author DOI 10.1158/1535-7163.mct-20-0144↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew M. Lowy · 3 shared papers, 2021–2025 · strength 0.54
- Paper The oncofetal protein IMP1 regulates the transcriptomic landscape to drive early events in pancreatic cancer progressio… DOI 10.1101/2024.06.28.601273↗
- Paper MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. DOI 10.1158/0008-5472.can-24-0744↗
- Paper Targeting the IGF-Axis Potentiates Immunotherapy for Pancreatic Ductal Adenocarcinoma Liver Metastases by Altering the … DOI 10.1158/1535-7163.mct-20-0144↗
- Orçun Haçarız · 1 shared paper, 2024 · strength 0.21
- Zu‐Hua Gao · 1 shared paper, 2024 · strength 0.21
- Divya Sood · 1 shared paper, 2025 · strength 0.17
- Bharti Garg · 1 shared paper, 2025 · strength 0.17
- Nirakar Rajbhandari · 1 shared paper, 2025 · strength 0.17
- Kevin Christian Montecillo Gulay · 1 shared paper, 2025 · strength 0.17
- Dawn Jaquish · 1 shared paper, 2025 · strength 0.17
- Cosimo Commisso · 1 shared paper, 2025 · strength 0.17
- Steve Gallinger · 1 shared paper, 2025 · strength 0.17
- Hervé Tiriac · 1 shared paper, 2025 · strength 0.17
- Masakazu Hashimoto · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.